Prothena | Ventas

Sales Cambio Fecha
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agios Pharmaceuticals USD 8.19M 1.09M 2024-03
ALKERMES USD 350.4M 27.08M 2024-03
Alnylam Pharmaceuticals USD 494.33M 54.61M 2024-03
Amgen USD 8.2B 1.29B 2023-12
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Exelixis USD 425M 54.65M 2024-03
Incyte USD 880.89M 132.45M 2024-03
Intra Cellular Therapies USD 132.1M 5.93M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
MacroGenics USD 10.72M 323K 2023-12
Neurocrine Biosciences USD 515.3M 100K 2024-03
Prothena USD 316K 84.55M 2023-12
Regeneron Pharmaceuticals USD 3.15B 284.3M 2024-03
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Prothena Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2024.